Our Products

At Marselus we are committed to advancing health through innovative and effective pharmaceutical and nutraceutical solutions. Our portfolio focuses on key therapeutic areas including Gastroenterology, Hepatology, Internal Medicine, and Women’s Health. Every product is designed with clinical efficacy, patient convenience, and safety in mind — supporting better outcomes through science-backed formulations.Explore our flagship offerings below:

NEPTIX 550

Rifaximin 550 mg TabletsIndication:NEPTIX 550 is indicated for:•Hepatic Encephalopathy – to reduce the risk of recurrent episodes•Irritable Bowel Syndrome with Diarrhea (IBS-D) – to alleviate symptoms including bloating and stool frequency•Traveler’s Diarrhea caused by non-invasive Escherichia coliProduct Overview:NEPTIX 550 features rifaximin, a gut-selective, non-systemic antibiotic with broad-spectrum activity. Its unique pharmacokinetic profile allows for targeted action in the gastrointestinal tract with minimal systemic absorption, making it highly effective and safe for long-term use.Key Features:•Gut-specific action with minimal systemic exposure•Well tolerated in chronic gastrointestinal conditions•Clinically validated for use in HE, IBS-D, and TD•Reduces intestinal ammonia-producing bacteria in hepatic encephalopathy•Low risk of resistance developmentTherapeutic Area: Gastroenterology, Hepatology, Internal MedicineAvailable Strengths: 550 mg tablet

ARTEMES

Mesalamine 1.2 g Prolonged Release TabletsIndication:ARTEMES is indicated for the induction and maintenance of remission in patients with Inflammatory Bowel Disease (IBD), including Ulcerative Colitis (UC) and Crohn’s Disease (CD).Product Overview:ARTEMES delivers a high-strength, prolonged-release formulation of mesalamine designed to provide targeted anti-inflammatory action throughout the colon. With once-daily dosing, it ensures patient convenience while optimizing therapeutic outcomes.Key Features:   •    Clinically proven to induce and maintain mucosal healing   •    Targeted delivery system for colon-specific release   •    Effective in reducing inflammation and preventing disease flares   •    High-dose (1.2g) once-daily formulation improves adherence   •    Well-established safety and tolerability profileTherapeutic Area: GastroenterologyAvailable Strengths: 1.2 g tablet (prolonged release)

SARANYA

Myo-Inositol 1100 mg + D-Chiro Inositol 400 mg + Chromium Picolinate 27.6 mcg + Vitamin D2 400 IU Tablets
Indication:
SARANYA is indicated for the dietary management of Polycystic Ovary Syndrome (PCOS) and associated conditions such as hormonal imbalance, insulin resistance, irregular menstrual cycles, and metabolic dysfunction.

Product Overview:
SARANYA is a scientifically formulated, dual inositol blend that supports hormonal health and metabolic balance in women with PCOS. The combination reflects the physiologic 2.75:1 ratio of Myo-inositol to D-Chiro-inositol, promoting ovarian function and insulin sensitivity.

Key Features:
   •    Clinically supported inositol ratio for improved ovulatory and metabolic outcomes
   •    Helps restore hormonal equilibrium and regular menstrual cycles
   •    Supports insulin sensitivity and glucose metabolism
   •    Fortified with Chromium Picolinate and Vitamin D2 for enhanced metabolic benefits
   •    Non-hormonal, well-tolerated and safe for long-term use

Therapeutic Area: Gynecology, Endocrinology, Reproductive Health
Available Format: Tablet (Nutraceutical formulation)